The Voices and Faces of Sarcoma
Editorial by Bruce Shriver, PhD
Letters to the Editor
Dr. Choong, Prof. Dass, and Mr. Broadhead. have shown that PEDF is capable of inhibiting the growth of osteosarcoma in a clinically relevant murine model.
PEDF: A Potential Therapeutic Agent for Osteosarcoma
In this study report, Dr. Choong, Prof. Dass, and Mr. Broadhead have shown that PEDF is capable of inhibiting the growth of osteosarcoma in a clinically relevant murine model.
Genomic and Molecular Characterization of EGFR and IGF1R as Key Potential Therapeutic Targets in Malignant Peripheral Nerve Sheath Tumors
In this experimental plan, Prof. Wei Zhang and Dr. Jilong Yang discuss their study to investigate if IGF1R and EGFR are potential therapeutic targets for the treatment of MPNSTs.
$50,000 Grant Awarded for MPNST Research
The Liddy Shriver Sarcoma Initiative and the Reid R. Sacco Memorial Foundation have awarded a $50,000 grant for malignant peripheral nerve sheath tumor research at the University of Texas M. D. Anderson Cancer Center and the Tianjin Medical University Cancer Hospital.
Two Internationally Distinguished Physicians Join ESUN's Medical Advisory and Editorial Board
We are pleased to announce that Dr. Frederick (Fritz) C. Eilber and Dr. Peter M. Schlag have joined our Medical Advisory and Editorial Board.
Rhabdomyosarcome (French)
Simon Baconnier, PhD and Elodie Espesset provide a French translation of the ESUN review article about rhabdomyosarcoma.
Sarcoma Sinovial (Spanish)
Dr. Ricardo Cubedo and Maria Jose provide a Spanish translation of the ESUN review article about synovial sarcoma.